Beclomethasone Dipropionate Rotacaps 200mcg (Generic)

Product Overview

Beclomethasone dipropionate is a synthetic glucocorticoid corticosteroid formulated for inhalation delivery. The Rotacaps formulation contains 200 micrograms of beclomethasone dipropionate per capsule, designed to be used with a standard Rotahaler device. Each pack includes 30, 60, or 90 capsules, providing a convenient, portable option for patients managing allergic rhinitis, asthma, or severe seasonal allergies. Manufactured by Cipla Limited, a globally recognized pharmaceutical company, the product meets stringent quality standards and is distributed worldwide. Its dry‑powder inhaler format ensures consistent dosing without the need for propellants, making it suitable for long‑term controller therapy. For more detailed information, you can view the FDA label

What is Beclomethasone Dipropionate Rotacaps 200mcg?

Beclomethasone dipropionate Rotacaps 200mcg refers to the specific dosage strength of the active ingredient contained within each Rotacap. The 200 microgram dose is typically prescribed for adults and adolescents aged 12 years and older who require moderate to high control of inflammatory airway conditions. As a generic medication, it contains the same therapeutic moiety as the branded inhalers but is offered at a cost‑effective price point. The capsules are intended for oral inhalation only and must be inserted into a compatible inhaler device before use. This form of beclomethasone belongs to the class of inhaled corticosteroids that reduce airway inflammation and hypersensitivity responses. Additional details are available on the NIH page on inhaled corticosteroids.

Uses and Benefits

The primary uses of Beclomethasone Dipropionate Rotacaps 200mcg encompass the prophylaxis and long‑term management of asthma, allergic rhinitis, and chronic urticaria associated with hypersensitivity. By attenuating the inflammatory cascade in the respiratory mucosa, the medication helps to prevent exacerbations, reduce nighttime symptoms, and improve overall lung function. Patients often experience fewer rescue inhaler visits and a lower reliance on oral steroids. Additionally, the Rotacap system offers a discreet, breath‑actuated administration that can be easily incorporated into daily routines, supporting adherence and sustained disease control. For official prescribing information, refer to the FDA label

How It Works

Beclomethasone dipropionate is a prodrug that undergoes intracellular conversion to the active metabolite beclomethasone, a potent glucocorticoid. Once deposited in the lungs, it binds to cytosolic glucocorticoid receptors, translocates to the nucleus, and modulates gene transcription to suppress the production of inflammatory cytokines such as interleukin‑4, interleukin‑5, and tumor necrosis factor‑alpha. This anti‑inflammatory action reduces edema, mucus hypersecretion, and airway hyperresponsiveness, thereby alleviating symptoms like wheezing, shortness of breath, and nasal congestion. The controlled release of the drug from the Rotacap ensures a steady therapeutic level with once‑or twice‑daily dosing. More mechanistic insight can be found in the NIH review of corticosteroid pathways.

Dosage Guidelines

Typical clinical regimens involve one inhalation (200 µg) administered twice daily, preferably in the morning and evening, to maintain consistent anti‑inflammatory coverage. The exact frequency may be adjusted by a healthcare professional based on disease severity, patient age, and concomitant therapies. For acute symptom control, a short course of oral corticosteroids may be prescribed under medical supervision. Patients should be instructed to prime the Rotacap device before the first use and to replace the capsule after each inhalation. It is essential to follow the prescribing clinician’s instructions and not to exceed the recommended dose without professional guidance. The FDA label provides detailed dosing recommendations.

Side Effects

Like all inhaled corticosteroids, Beclomethasone Dipropionate Rotacaps 200mcg may be associated with adverse effects, although most are mild and transient. Common side effects include oral thrush, hoarseness, and irritation of the throat or nasopharynx. Rarely, users may experience headache, dizziness, or increased heart rate. Prolonged high‑dose use can potentially affect bone mineral density, particularly in post‑menopausal women, so routine monitoring is advised. If visual disturbances, persistent sore throat, or signs of systemic infection develop, patients should seek medical attention promptly. Reporting any unexpected reactions to a healthcare provider ensures timely management. For comprehensive safety data, consult the FDA label

Warnings and Precautions

Patients with a known hypersensitivity to beclomethasone or any excipients should avoid this medication. Caution is warranted in individuals with active tuberculosis, fungal infections, or untreated viral respiratory conditions, as systemic absorption may exacerbate these disorders. The drug is not indicated for the treatment of acute asthma attacks; rescue medication such as a short‑acting bronchodilator should be available. Pregnant or lactating women should consult a physician before use, as the risk to the fetus or infant is not fully established. Regular clinical review every 3–6 months helps assess disease control, airway function, and the need for dose adjustment. Additional guidance is provided by the FDA label

Frequently Asked Questions

1. What condition does Beclomethasone Dipropionate Rotacaps 200mcg treat? It is indicated for the long‑term control of asthma, allergic rhinitis, and severe allergic reactions. The medication reduces inflammation in the airways and nasal passages, helping to prevent symptom flare‑ups and improve daily functioning. It is not intended for immediate relief of acute attacks; a short‑acting bronchodilator should be used as rescue therapy when needed.
2. How should the Rotacap be used with a Rotahaler device? To use the Rotacap, insert a capsule into the mouthpiece of the Rotahaler, then twist the device to puncture the capsule and release the powder. Inhale deeply and steadily through the mouthpiece for about two seconds, hold the breath for approximately 10 seconds, and then exhale. Each capsule is single‑use; discard it after inhalation. Proper technique ensures optimal drug delivery and minimizes waste.
3. Can children use Beclomethasone Dipropionate Rotacaps 200mcg? The 200 µg strength is approved for adolescents aged 12 years and older. For younger children, a lower dose or a different formulation may be required, and dosing must be individualized by a pediatric healthcare provider. Parents should not administer the medication without a physician’s prescription and should monitor for any adverse effects. For pediatric dosing guidelines, refer to the FDA label.
4. Is Beclomethasone Dipropionate the same as Fluticasone? Both are inhaled corticosteroids used for asthma and allergy management, but they differ in chemical structure, potency, and dosing schedules. Beclomethasone dipropionate and fluticasone propionate are not interchangeable without medical supervision, as switching may affect disease control. Clinicians choose the appropriate agent based on patient response, comorbidities, and prior treatment history. For comparative information, see the NIH monograph on inhaled steroids.
5. Where can I find the official prescribing information for Beclomethasone Dipropionate Rotacaps 200mcg? The complete FDA‑approved label, including indications, contraindications, and dosing recommendations, is available online through the Drugs.com database and the official FDA label page. Additionally, the European Medicines Agency (EMA) provides a summary of product characteristics for the European market. These resources contain detailed safety and usage data for healthcare professionals and patients.